Blockade MedicalTM Announces First 100 Patients Treated with the Barricade Coil System
IRVINE, Calif.--(BUSINESS WIRE)--Jan 14, 2013--Blockade Medical LLC, a privately held company focused on the development of catheter based therapeutic devices for the treatment of cerebral aneurysms, announced today that more than 100 patients have been successfully treated with the Barricade Coil System TM. The patients treated, presented with a wide range of cerebral aneurysms and peripheral lesions. All treated patients had positive clinical outcomes without any reported complications.
“The Barricade Coil System provides excellent overall performance for the treatment of cerebral aneurysms. We have successfully treated a variety of aneurysm morphologies and in my clinical experience the Barricade finishing coil is the softest finishing coil available on the market today,” commented Amit Herwadkar, M.D. from Salford Hospital in Manchester, United Kingdom.
Upon completion of the first 100 patients treated, Blockade Medical’s CEO, Gibb Clarke said, “The successful treatment of 100 patients with the Barricade Coil System represents an important milestone for the company. Within a few months’ time, Blockade has experienced rapid adoption of the Barricade Coil System across Europe and other markets and view this milestone as a very positive indicator of our successful clinical experience. We are excited by the opportunity before us and look forward to making a positive impact for patients suffering from cerebral aneurysms.” Blockade Medical initiated commercial sales of the Barricade Coil System in September of 2012. The company is now organized to sell in over 25 countries and expects additional market commercialization during 2013 as regulatory approvals are obtained. The Barricade Coil System is the first of several products to be introduced by Blockade Medical.
About the Barricade Coil System: The Barricade Coil System is an embolization coil line which is designed to endovascularly occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels. The Barricade Coil System is a comprehensive bare platinum coil line available in framing, filling and finishing shapes. The Barricade Coil System received CE Mark in July, 2012.
About Blockade Medical: Blockade Medical is a privately held medical device company focused on expanding the endovascular management of hemorrhagic stroke and related disease of the neurovascular system. The company manufactures the Barricade Coil System in The United States and is based in Irvine, California.CONTACT: Blockade Medical Ryan Solomon Director of Global Marketing 949-788-1443 KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES SOURCE: Blockade Medical LLC Copyright Business Wire 2013 PUB: 01/14/2013 08:06 AM/DISC: 01/14/2013 08:06 AM http://www.businesswire.com/news/home/20130114005196/